Unicycive Therapeutics Inc

UNCY NASDAQ Santé & Biotech États-Unis US90466Y1038
7.60 $
2.98 %

Unicycive Therapeutics développe des traitements pour les maladies rénales chroniques et aiguës.

Performance & Momentum

6 Months 22.25 %
1 Year 24.96 %
3 Years 46.46 %
5 Years 77.08 %

Similar stocks to Unicycive Therapeutics Inc

Anantys Community

Be the first to share your analysis on Unicycive Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases